Table 1 The difference in treatment patterns between the two groups
From: The impact of the COVID-19 Pandemic on rhegmatogenous retinal detachment treatment patterns
(n, %) | The COVID-19 pandemic group (79) | The pre-COVID-19 group (179) | P |
|---|---|---|---|
PPV (n, %) | 57, 72.2% | 105, 58.6% | 0.04 |
 combined with SB | 1, 1.8% | 0, 0% | 0.31 |
 combined with PHACO | 4, 7.0% | 22, 21.0% | 0.02 |
 silicone oil tamponade | 52, 91.2% | 91, 86.7% | 0.45 |
 C3F8 tamponade | 5, 8.8% | 14, 13.3% | 0.79 |
SB (n, %) | 22, 27.8% | 74, 41.3% | 0.01 |
 segmental buckle | 8, 25.8% | 15, 11.5% | 0.06 |
 radial buckle | 1, 3.2% | 6, 4.6% | 0.59 |
 combined encircling | 13, 59.1% | 53, 71.6% | 0.62 |
 drainage of subretinal fluid | 10, 45.4% | 56, 75.7% | 0.01 |